NCT03852550

Brief Summary

The purpose of this study is to find out if there is a benefit to using the MyREADY Transition\[TM\] BBD App for brain-based disabilities, compared to not using it. To do this, some of the participants in this study will use the MyREADY Transition\[TM\] BBD App and others will not use the App. Everyone will continue to get the same care they have been getting (their usual care). The study team wants to see how youth will use the MyREADY Transition\[TM\] BBD App as they are getting ready to leave the children's hospital or children's treatment centre. And, they want to see if it will help youth to be knowledgeable about their own health. The study team hopes to see youth taking steps to develop the skills so they become better managers of their health. For example, this would include knowing about their medication or knowing when to ask for help from parents/caregivers and health care providers.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

9 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 25, 2019

Completed
1.3 years until next milestone

Study Start

First participant enrolled

June 22, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2023

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

March 21, 2025

Completed
Last Updated

March 21, 2025

Status Verified

November 1, 2024

Enrollment Period

2.9 years

First QC Date

February 19, 2019

Results QC Date

July 15, 2024

Last Update Submit

March 4, 2025

Conditions

Keywords

Health Care TransitionBrain-Based DisabilitiesCHILD-BRIGHTe-health applicationrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Transition Readiness Assessment Questionnaire (TRAQ) Change

    While Transition Readiness Assessment Questionnaire (TRAQ) measure refinement is ongoing, and other versions are now available, our sample size calculation is based on findings from an intervention trial where the 29-item version of the TRAQ was used. The 29-item version has a Self-management domain score (16 items) and a Self-advocacy domain score (13 items). Both the TRAQ Self-management and TRAQ Self-advocacy domain scores are reported. Scores range from 1 to 5. Higher scores mean better transition readiness.

    Baseline and 6-Month Visit

Secondary Outcomes (7)

  • Canadian Occupational Performance Measure (COPM) Change

    Baseline and 6-Month Visit

  • TRANSITION-Q Change

    Baseline and 6-Month Visit

  • Pediatric Quality of Life Instrument (PedsQL[TM]) Change

    Baseline and 6-Month Visit

  • Measure of Process of Care (MPOC) Change

    Baseline and 6-Month Visit

  • Health Utilities Index® (Hui2/3) Proxy-Assessed Change

    Baseline and 6-Month Visit

  • +2 more secondary outcomes

Other Outcomes (1)

  • Utilization of Intervention (Usage, Adherence, and Fidelity)

    6-Month Visit

Study Arms (2)

Usual Care + MyREADYTransition[TM] BBD App

EXPERIMENTAL

Participants in the experimental Intervention group continue to get the same care they have been getting (their usual care) and they receive the MyREADY Transition\[TM\] BBD App e-health application. There are 19 parts in the App with videos and games to help youth learn and practice ways to manage their health. There are approximately 5-7 hours of content in total. Participants will be asked to wait at least one day between the parts. There is a timer in the App to help to moderate pace and align with how young people learn and digest information. Participants can choose how much time they want to take to do the App. It is recommended that participants make their own routine for using it. The recommended shortest and longest intervention exposure times are: 1 part each day (this will take 19 days to do all of the App), 1 part each week (this will take 19 weeks to do all of the App).

Other: e-health application

Control Group: Usual Care

NO INTERVENTION

Participants in the no intervention Control group continue to get the same care they have been getting (their usual care). The researchers aim to supply the App to participants in both the intervention and control group for a limited time after participation in the study.

Interventions

In the first part of this study, an e-health application (MyREADY Transition\[TM\] BBD App) was developed, targeting the needs of youth with BBD during their transition and transfer from pediatric to adult health care. Program development centered on three core foci of health care transition planning: education, empowerment, and navigation. The intervention has an emphasis on the process of transition in which youth and young adults learn information and develop skills in order to eventually assume maximal responsibility for self-management of their conditions (e.g., learning how to speak directly with health providers) while also providing information to prepare youth for the event of the transfer from pediatric to adult health care.

Also known as: MyREADY Transition[TM] BBD App
Usual Care + MyREADYTransition[TM] BBD App

Eligibility Criteria

Age15 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Youth with chronological age between 15 and 17 years of age (i.e. before 18th birthday), in one of the four Canadian study regions (Alberta, Ontario, Quebec, Maritimes), followed in pediatric care and for whom a discharge from pediatric care is planned but not for at least 6 months.
  • A diagnosis of one of the following neurological brain-based disabilities: autism spectrum disorder, cerebral palsy, epilepsy, spina bifida, or fetal alcohol spectrum disorder.
  • Cognitive ability to provide informed consent and the ability to read and understand English or French.
  • Access to internet and a smartphone, iPad/tablet or desktop computer.
  • TRANSITION-Q score \>40 (as a screen to define a minimum threshold for transition readiness based on earlier work).

You may not qualify if:

  • Youth is in "acute crisis" with unstable physical or mental health that would interfere with the ability to participate in the study.
  • Sensory impairments, such as uncorrected vision or hearing loss, which interfere with use of the App intervention.
  • Enrolled in a potentially confounding trial (e.g., a different transition intervention study).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Alberta Health Services and The Governors of the University of Alberta

Edmonton, Alberta, T6G 2C8, Canada

Location

Horizon Health Network

Saint John, New Brunswick, E3B 4R3, Canada

Location

Izaak Walton Killam Health Centre (IWK)

Halifax, Nova Scotia, B3K 6R8, Canada

Location

McMaster Children's Hospital, Hamilton Health Sciences

Hamilton, Ontario, L8L 8E7, Canada

Location

Lawson Health Research Institute

London, Ontario, N6C 2R5, Canada

Location

Children's Hospital of Eastern Ontario Research Institute Inc.

Ottawa, Ontario, K1H 8L1, Canada

Location

Holland Bloorview Kids Rehabilitation Hospital

Toronto, Ontario, M4G 1R8, Canada

Location

Centre Hospitalier Universitaire Sainte-Justine

Montreal, Quebec, H3T 1C5, Canada

Location

Research Institute of the McGill University Health Centre

Montreal, Quebec, H4A 3J1, Canada

Location

Related Publications (2)

  • Gorter JW, Amaria K, Kovacs A, Rozenblum R, Thabane L, Galuppi B, Nguyen L, Strohm S, Mahlberg N, Via-Dufresne Ley A, Marelli A; CHILD-BRIGHT READYorNotTM Brain-Based Disabilities Trial Study Group; CHILD-BRIGHT READYorNot(TM) Brain-Based Disabilities Trial Study Group. CHILD-BRIGHT READYorNot Brain-Based Disabilities Trial: protocol of a randomised controlled trial (RCT) investigating the effectiveness of a patient-facing e-health intervention designed to enhance healthcare transition readiness in youth. BMJ Open. 2021 Mar 26;11(3):e048756. doi: 10.1136/bmjopen-2021-048756.

    PMID: 33771833BACKGROUND
  • Marelli A, Rozenblum R, Bolster-Foucault C, Via-Dufresne Ley A, Maynard N, Amaria K, Galuppi B, Strohm S, Nguyen L, Dawe-McCord C, Putterman C, Kovacs AH, Gorter JW. Development of MyREADY Transition BBD Mobile App, a Health Intervention Technology Platform, to Improve Care Transition for Youth With Brain-Based Disabilities: User-Centered Design Approach. JMIR Pediatr Parent. 2024 Oct 1;7:e51606. doi: 10.2196/51606.

Related Links

MeSH Terms

Conditions

Autism Spectrum DisorderCerebral PalsyEpilepsyFetal Alcohol Spectrum DisordersSpinal Dysraphism

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesFetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAlcohol-Induced DisordersAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersNeural Tube DefectsNervous System MalformationsCongenital Abnormalities

Limitations and Caveats

The planned sample size was 264; 43 participants completed follow-up. With significant start-up delays and recruitment curtailed by the COVID-19 pandemic, the limited feasibility to recruit our sample ultimately led to the early stop of the trial. As approved by ethics, we dropped the health economic outcome analysis (Health card number linking, Health Utilities Index (HUI), Resource Use Questionnaire (RUQ)) and destroy stored health card number data.

Results Point of Contact

Title
Research Coordinator
Organization
McMaster University

Study Officials

  • Jan Willem Gorter, MD,PhD,FRCPC

    McMaster University

    PRINCIPAL INVESTIGATOR
  • Ariane Marelli, MD,MPH,FRCPC

    McGill University

    PRINCIPAL INVESTIGATOR
  • Adrienne Kovacs, PhD,CPsych

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Embedded experimental model design, embedding a qualitative component within the randomized controlled trial (RCT). Randomization will be stratified by region with a 1:1 allocation ratio for patients: intervention group (receiving MyREADY Transition\[TM\] BBD App intervention) or control group (continuing with usual care). The unit of randomization is the patient, using variable block randomization with block sizes of 2, 4, 6 and 8.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2019

First Posted

February 25, 2019

Study Start

June 22, 2020

Primary Completion

May 22, 2023

Study Completion

May 22, 2023

Last Updated

March 21, 2025

Results First Posted

March 21, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations